ASPSCR1
Tether containing UBX domain for GLUT4
Also known as: ASPC1_HUMAN, ASPL, ASPS, TUG, UBXD9, UBXN9
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZE9
- Gene
- ASPSCR1
- Ensembl
- ENSG00000169696
- Chromosome
- 17
- Canonical length
- 553 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane
OverviewNCBI Gene
The protein encoded by this gene contains a UBX domain and interacts with glucose transporter type 4 (GLUT4). This protein is a tether, which sequesters the GLUT4 in intracellular vesicles in muscle and fat cells in the absence of insulin, and redistributes the GLUT4 to the plasma membrane within minutes of insulin stimulation. Translocation t(X;17)(p11;q25) of this gene with transcription factor TFE3 gene results in a ASPSCR1-TFE3 fusion protein in alveolar soft part sarcoma and in renal cell carcinomas. Multiple alternatively spliced transcript variants have been found. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
553 residues, UniProt reviewed canonical sequence.
>Q9BZE9|ASPSCR1
1 MAAPAGGGGS AVSVLAPNGR RHTVKVTPST VLLQVLEDTC RRQDFNPCEY DLKFQRSVLD
61 LSLQWRFANL PNNAKLEMVP ASRSREGPEN MVRIALQLDD GSRLQDSFCS GQTLWELLSH
121 FPQIRECLQH PGGATPVCVY TRDEVTGEAA LRGTTLQSLG LTGGSATIRF VMKCYDPVGK
181 TPGSLGSSAS AGQAAASAPL PLESGELSRG DLSRPEDADT SGPCCEHTQE KQSTRAPAAA
241 PFVPFSGGGQ RLGGPPGPTR PLTSSSAKLP KSLSSPGGPS KPKKSKSGQD PQQEQEQERE
301 RDPQQEQERE RPVDREPVDR EPVVCHPDLE ERLQAWPAEL PDEFFELTVD DVRRRLAQLK
361 SERKRLEEAP LVTKAFREAQ IKEKLERYPK VALRVLFPDR YVLQGFFRPS ETVGDLRDFV
421 RSHLGNPELS FYLFITPPKT VLDDHTQTLF QANLFPAALV HLGAEEPAGV YLEPGLLEHA
481 ISPSAADVLV ARYMSRAAGS PSPLPAPDPA PKSEPAAEEG ALVPPEPIPG TAQPVKRSLG
541 KVPKWLKLPA SKRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ASPSCR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- liver: 59 nTPM
- skeletal muscle: 44 nTPM
- pituitary gland: 32 nTPM
- testis: 30 nTPM
- kidney: 28 nTPM
- thyroid gland: 26 nTPM
Single-cell type
- extravillous trophoblasts: 389 nCPM
- late spermatids: 145 nCPM
- cytotrophoblasts: 97 nCPM
- myonuclei: 89 nCPM
- hepatocytes: 72 nCPM
- undifferentiated spermatogonia: 72 nCPM
Immune cell
- basophil: 24 nTPM
- myeloid DC: 15 nTPM
- classical monocyte: 12 nTPM
- non-classical monocyte: 11 nTPM
- memory CD4 T-cell: 10 nTPM
- plasmacytoid DC: 9.4 nTPM
Brain region
- white matter: 37 nTPM
- medulla oblongata: 36 nTPM
- cerebral cortex: 33 nTPM
- choroid plexus: 32 nTPM
- pons: 32 nTPM
- thalamus: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 0
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glucose homeostasis
- intracellular protein transport
- positive regulation of protein modification process
- regulation of D-glucose import
Cellular components
Protein domainsUniProt · Pfam · InterPro
- UBX domain
- Ubiquitin-like domain superfamily
- UBX domain
- TUG ubiquitin-like domain
- UBX domain protein 9, Ubiquitin regulatory domain X 1
- TUG ubiquitin-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ASPSCR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ASPSCR1 as an antibody target. Whether an autoantibody or antibody against ASPSCR1 could matter depends on whether native ASPSCR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ASPSCR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ASPSCR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...